Aspire-Lakewood Holdings, Inc. (ASBP) stock
ASBPNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ASBPW
$8.30+0.24 (+2.98%)
Close on Nov 17, 2026Market cap $11.64MP/E –Yield –
Aspire-Lakewood r&d expenses
Research and development expenses are spending on new products and technology.
Aspire-Lakewood's R&D Expenses for the twelve months ending Jun 30, 2026 was $838.14K, up 13.4% year over year. For fiscal 2025 it was $923.91K, up 540.0% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $923.91K | +540.0% |
| FY2024 | Dec 31, 2024 | $144.36K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $233.48K | -33.8% |
| Q1 FY2026 | Mar 31, 2026 | $296.72K | +12.8% |
| Q4 FY2025 | Dec 31, 2025 | $100.04K | -14.0% |
| Q3 FY2025 | Sep 30, 2025 | $207.90K | +2870.0% |
| Q2 FY2025 | Jun 30, 2025 | $352.89K | +3260.8% |
| Q1 FY2025 | Mar 31, 2025 | $263.09K | +2405.6% |
| Q4 FY2024 | Dec 31, 2024 | $116.36K | – |
| Q3 FY2024 | Sep 30, 2024 | $7.00K | – |
| Q2 FY2024 | Jun 30, 2024 | $10.50K | – |
| Q1 FY2024 | Mar 31, 2024 | $10.50K | – |
See a number that looks wrong?